THE MARCO CLINICAL RESEARCH STUDY IS NOW ENROLLING PEDIATRIC PATIENTS WITH CONSTIPATION

FOR IMMEDIATE RELEASE

THE MARCO CLINICAL RESEARCH STUDY IS NOW ENROLLING PEDIATRIC PATIENTS WITH CONSTIPATION

Johnstown, PA, February 25, 2016 – Physicians across the nation are pleased to announce that the Marco Clinical Research Study is now enrolling pediatric patients with constipation at 50 participating locations in the US.

Constipation in children is a frequent problem and parents commonly seek medical help to resolve it. Studies have reported constipation in up to 23% of children 17 or younger.1 Constipation is cited as the primary complaint in 3 – 5% of pediatric outpatient visits. 1

The hallmarks of pediatric Functional Constipation are infrequent bowel movements. Clinical criteria for diagnosing the condition have been established at 2 or fewer bowel movements per week. Affected children may actively try to stop their bowel movements.

Medical help for these patients has lagged but this new clinical research study will evaluate the investigational use in children of a study drug that has already been approved by the FDA to treat adults with symptoms of constipation. Physicians are currently enrolling the Marco Clinical Research Study for patients aged 6 – 17 who have Functional Constipation and who, at least for the past 2 months, have had 2 or fewer bowel movements each week, may actively try to stop their bowel movements or exhibit retentive posturing, where they stand straight, on their toes, or have a red face as they try to stop their bowel movements. They may also have painful or hard bowel movements.

For more information and to learn about additional eligibility criteria, please contact 1-888-609-3456 or additional information is available at www.marco-polostudies.com .

1. Borowitz, SM. http://emedicine.medscape.com/article/928185-overview

###